Search research articles
Contact Us
Filters
Showing results (201-210 of 222) with videos related to
Page
of 23
Sort By:
Acta Pharmacologica Sinica
|
December 11, 2021
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-Cai Xu, Li Yang, Pei-Quan Zhang, et al.
Plos One
|
April 3, 2014
Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis
Vino T Cheriyan, Ying Wang, Magesh Muthu, et al.
Plos One
|
November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro
Hongbiao Huang, Ningning Liu, Haiping Guo, et al.
The Prostate
|
February 7, 2014
Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer
Christine Neslund-Dudas, Albert M Levin, Andrew Rundle, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
Structure-activity relationships OF N-methylthiolated beta-lactam antibiotics with C3 substitutions and their selective induction of apoptosis in human cancer cells
Deborah J Kuhn, Yang Wang, Vesna Minic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2013
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation
Xianping Shi, Xin Chen, Xiaofen Li, et al.
Oncotarget
|
September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Xin Chen, Xianping Shi, Chong Zhao, et al.
Nutrients
|
November 8, 2018
Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells
Joshua R Heyza, Sanjeevani Arora, Hao Zhang, et al.
Cancer Letters
|
January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activity
Hongbiao Huang, Di Chen, Shujue Li, et al.
Plos One
|
January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo
Hongbiao Huang, Ningning Liu, Changshan Yang, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 222) with videos related to
Sort By:
Page
of 23
Acta Pharmacologica Sinica
|
December 11, 2021
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-Cai Xu, Li Yang, Pei-Quan Zhang, et al.
Plos One
|
April 3, 2014
Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis
Vino T Cheriyan, Ying Wang, Magesh Muthu, et al.
Plos One
|
November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro
Hongbiao Huang, Ningning Liu, Haiping Guo, et al.
The Prostate
|
February 7, 2014
Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer
Christine Neslund-Dudas, Albert M Levin, Andrew Rundle, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
March 17, 2005
Structure-activity relationships OF N-methylthiolated beta-lactam antibiotics with C3 substitutions and their selective induction of apoptosis in human cancer cells
Deborah J Kuhn, Yang Wang, Vesna Minic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2013
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation
Xianping Shi, Xin Chen, Xiaofen Li, et al.
Oncotarget
|
September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Xin Chen, Xianping Shi, Chong Zhao, et al.
Nutrients
|
November 8, 2018
Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells
Joshua R Heyza, Sanjeevani Arora, Hao Zhang, et al.
Cancer Letters
|
January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activity
Hongbiao Huang, Di Chen, Shujue Li, et al.
Plos One
|
January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo
Hongbiao Huang, Ningning Liu, Changshan Yang, et al.
Page
of 23